⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3982648 | 0.83 | — | — | |
| SCHEMBL31310949 | 0.79 | — | — | |
| SCHEMBL10970405 | 0.79 | — | — | |
| SCHEMBL11684926 | 0.78 | — | — | |
| SCHEMBL10429479 | 0.77 | — | — | |
| SCHEMBL11335511 | 0.77 | — | — | |
| SCHEMBL5329389 | 0.75 | — | — | |
| SCHEMBL11872460 | 0.75 | — | — | |
| SCHEMBL28159224 | 0.69 | — | — | |
| SCHEMBL8847376 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2302000-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2016-11-16 | — | — | EP | disclosed |
| US-9051501-B2 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2015-06-09 | — | — | US | disclosed |
| EP-2100923-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2013-03-13 | — | — | EP | disclosed |
| EP-2088173-B1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORP (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-8008386-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-08-30 | — | — | US | disclosed |
| EP-2302000-A1 | Curable composition and catalyst composition | KANEKA CORPORATION (JP) | 2011-03-30 | — | — | EP | disclosed |
| US-20100063215-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100041810-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | KANEKA CORPORATION (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2100923-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2009-09-16 | — | — | EP | disclosed |
| EP-2088173-A1 | CURABLE COMPOSITION AND CATALYST COMPOSITION | Kaneka Corporation (JP) | 2009-08-12 | — | — | EP | disclosed |
| EP-0777703-A2 | DICYCLIC METAL COMPLEX FORMAZAN DERIVATIVES, PROCESS FOR PRODUCING THE SAME, COMPOSITION CONTAINING THE SAME AND DYEING PROCESS EMPLOYING THE SAME | Kyungin Synthetic Corporation (KR) | 1997-06-11 | — | — | EP | disclosed |
| WO-1996033240-A2 | DICYCLIC METAL COMPLEX FORMAZAN DERIVATIVES, PROCESS FOR PRODUCING THE SAME, COMPOSITION CONTAINING THE SAME AND DYEING PROCESS EMPLOYING THE SAME | KYUNG-IN SYNTHETIC CORPORATION (KR) | 1996-10-24 | — | — | WO | disclosed |
| EP-0280139-B1 | COMPLEX COPPER FORMAZANE COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE AS DYESTUFFS | HOECHST AKTIENGESELLSCHAFT (DE) | 1992-01-22 | — | — | EP | disclosed |
| EP-0280139-A2 | Complex copper formazane compounds, process for their preparation and their use as dyestuffs | HOECHST AKTIENGESELLSCHAFT (DE) | 1988-08-31 | — | — | EP | disclosed |